p-aminohippuric acid has been researched along with Chronic Kidney Failure in 29 studies
p-Aminohippuric Acid: The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity.
p-aminohippurate : A hippurate that is the conjugate base of p-aminohippuric acid, arising from deprotonation of the carboxy group.
p-aminohippuric acid : An N-acylglycine that is the 4-amino derivative of hippuric acid; used as a diagnostic agent in the measurement of renal plasma flow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, after 6 mo of Valsartan treatment, proteinuria was reduced by 396 +/- 323 mg/24 h (26 +/- 18%) and albuminuria by 531 +/- 499 mg/24 h (41 +/- 21%) with regard to baseline values (P < 0." | 6.69 | Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. ( Bünten, B; Grabensee, B; Németh, R; Plum, J, 1998) |
| "Fenofibrate is a potent hypolipemic agent, widely used in patients with mild to severe renal failure in whom hyperlipoproteinemia is frequent." | 5.09 | [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency]. ( Achard, JM; el Esper, N; Fournier, A; Hottelart, C; Pruna, A, 1999) |
| " 51Chromium-ethylenediamine tetraacetic acid, para-amino hippuric acid, lithium, and sodium clearances, measurements of serum and urinary electrolytes, and urinary concentration tests were performed." | 3.69 | Kidney function in cyclosporine-treated pediatric heart transplant recipients. ( Holmberg, C; Jalanko, H; Laine, J; Leijala, M; Sairanen, H, 1997) |
| "However, after 6 mo of Valsartan treatment, proteinuria was reduced by 396 +/- 323 mg/24 h (26 +/- 18%) and albuminuria by 531 +/- 499 mg/24 h (41 +/- 21%) with regard to baseline values (P < 0." | 2.69 | Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. ( Bünten, B; Grabensee, B; Németh, R; Plum, J, 1998) |
| "The progress of chronic renal failure (CRF) is characterized by the development of glomerular and tubular lesions." | 1.33 | Altered renal elimination of organic anions in rats with chronic renal failure. ( Anzai, N; Brandoni, A; Endou, H; Mac Laughlin, M; Mónica Torres, A; Muller, A, 2005) |
| "However, their changes in chronic renal failure (CRF) are poorly understood." | 1.31 | Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. ( Inui, K; Ji, L; Masuda, S; Saito, H, 2002) |
| "End-state renal disease (ESRD) affects 300000 people in the United States each year." | 1.31 | High-throughput multi-analyte screening for renal disease using capillary electrophoresis. ( Clark, EA; Fanguy, JC; Henry, CS, 2001) |
| " Serum IGFBP-3 levels fell while IGFBP-1 and -2 levels rose during treatment, changes that likely affect the bioavailability of IGF-I." | 1.30 | Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure. ( Fervenza, FC; Hintz, RL; Hoffman, AR; Ike, JO; Liu, F; Rabkin, R; Yeh, I, 1997) |
| "Ten patients with chronic renal failure whose hypertension was controlled with triple drug therapy consisting of propranolol-hydralazine-furosemide were switched to the angiotensin-converting enzyme (ACE) inhibitor captopril for a period of 12 months." | 1.28 | Converting enzyme inhibition in chronic renal failure. ( Miranda, B; Morales, JM; Raij, L; Rodicio, JL; Romero, JC; Ruilope, LM, 1989) |
| " The dose-response curve is similar to that of a known competitive inhibitor, hippuric acid, and the average inhibitory activity of uremic extract as derived from these curves was 3." | 1.26 | Suppression of tubular anion transport by an inhibitor of serum protein binding in uremia. ( Depner, TA, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (20.69) | 18.7374 |
| 1990's | 13 (44.83) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, L | 1 |
| Masuda, S | 1 |
| Saito, H | 1 |
| Inui, K | 1 |
| Agarwal, R | 1 |
| Vasavada, N | 1 |
| Chase, SD | 1 |
| Appenroth, D | 2 |
| Beutinger, R | 1 |
| Lupp, A | 1 |
| Fleck, C | 2 |
| Sutter, L | 1 |
| Koch, B | 1 |
| Meinhold, T | 1 |
| Pitack, M | 1 |
| Gasser, R | 1 |
| Mónica Torres, A | 1 |
| Mac Laughlin, M | 1 |
| Muller, A | 1 |
| Brandoni, A | 1 |
| Anzai, N | 1 |
| Endou, H | 1 |
| Schwarz, A | 1 |
| Rustien, G | 1 |
| Merkel, S | 1 |
| Radermacher, J | 1 |
| Haller, H | 1 |
| Franz, KA | 1 |
| Reubi, FC | 1 |
| Depner, TA | 1 |
| Yü, TF | 1 |
| Berger, L | 1 |
| Maxwell, H | 1 |
| Nair, DR | 1 |
| Dalton, RN | 1 |
| Rigden, SP | 1 |
| Rees, L | 1 |
| Miller, SB | 2 |
| Moulton, M | 1 |
| O'Shea, M | 1 |
| Hammerman, MR | 2 |
| Prescott, LF | 2 |
| Freestone, S | 2 |
| McAuslane, JA | 2 |
| O'Shea, MH | 1 |
| Cortsen, M | 1 |
| Petersen, LJ | 1 |
| Ståhlberg, F | 1 |
| Thomsen, C | 1 |
| Søndergaard, L | 1 |
| Petersen, JR | 1 |
| Ladefoged, SD | 1 |
| Henriksen, O | 1 |
| Ike, JO | 1 |
| Fervenza, FC | 1 |
| Hoffman, AR | 1 |
| Yeh, I | 1 |
| Hintz, RL | 1 |
| Liu, F | 1 |
| Rabkin, R | 1 |
| Laine, J | 1 |
| Jalanko, H | 1 |
| Leijala, M | 1 |
| Sairanen, H | 1 |
| Holmberg, C | 1 |
| Plum, J | 1 |
| Bünten, B | 1 |
| Németh, R | 1 |
| Grabensee, B | 1 |
| Roy, L | 1 |
| Legault, L | 1 |
| Pomier-Layrargues, G | 1 |
| Hottelart, C | 1 |
| el Esper, N | 1 |
| Achard, JM | 1 |
| Pruna, A | 1 |
| Fournier, A | 1 |
| Pastore, A | 1 |
| Bernardini, S | 1 |
| Dello Strologo, L | 1 |
| Rizzoni, G | 1 |
| Cortese, C | 1 |
| Federici, G | 1 |
| Clark, EA | 1 |
| Fanguy, JC | 1 |
| Henry, CS | 1 |
| Deguchi, T | 1 |
| Ohtsuki, S | 1 |
| Otagiri, M | 1 |
| Takanaga, H | 1 |
| Asaba, H | 1 |
| Mori, S | 1 |
| Terasaki, T | 1 |
| Guidi, E | 1 |
| Minetti, EE | 1 |
| Cozzi, MG | 1 |
| Berg, KJ | 1 |
| Brooks, DP | 1 |
| Goldstein, R | 1 |
| Koster, PF | 1 |
| DePalma, PD | 1 |
| DiCristo, M | 1 |
| Karpinski, K | 1 |
| Hyneck, M | 1 |
| Deray, G | 1 |
| Cacoub, P | 1 |
| Jacquiaud, C | 1 |
| Drobinski, G | 1 |
| Brillet, G | 1 |
| Bunker, D | 1 |
| Jaudon, MC | 1 |
| Jacobs, C | 1 |
| Drobinski, M | 1 |
| Ruilope, LM | 1 |
| Miranda, B | 1 |
| Morales, JM | 1 |
| Rodicio, JL | 1 |
| Romero, JC | 1 |
| Raij, L | 1 |
| Gloff, CA | 1 |
| Benet, LZ | 1 |
6 trials available for p-aminohippuric acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.
Topics: Adolescent; Blood Pressure; Body Height; Child; Child, Preschool; Creatinine; Female; Glomerular Fil | 1995 |
Effects of IGF-I on renal function in end-stage chronic renal failure.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Humans; Insulin-Like Growth Factor I; Inulin; Kidne | 1994 |
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Cre | 1998 |
[Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Topics: Aged; Creatinine; Cross-Over Studies; Female; Fenofibrate; Glomerular Filtration Rate; Humans; Hyper | 1999 |
Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Glomerular Filtration Rate; Glom | 2002 |
Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; beta 2-Microglobulin; Dinoprostone; Glomerular Filtr | 1991 |
23 other studies available for p-aminohippuric acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.
Topics: Animals; Cimetidine; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Estradiol; Gonadal | 2002 |
Liquid chromatography for iothalamate in biological samples.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calibration; Chromatography, High Pressure Liquid; Contr | 2003 |
Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease | 2003 |
Use of gene chip technology for the characterisation of the regulation of renal transport processes and of nephrotoxicity in rats.
Topics: Aging; Animals; Biological Transport; Dexamethasone; Disease Models, Animal; Female; Gene Expression | 2003 |
Altered renal elimination of organic anions in rats with chronic renal failure.
Topics: Animals; Anions; Blood Pressure; Creatinine; Kidney; Kidney Failure, Chronic; Male; Organic Anion Tr | 2005 |
Decreased renal transplant function after parathyroidectomy.
Topics: Biopsy; Calcinosis; Calcium; Creatinine; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Sec | 2007 |
Rate of functional deterioration in polycystic kidney disease.
Topics: Adult; Age Factors; Aged; Chromium Radioisotopes; Creatinine; Edetic Acid; Follow-Up Studies; Glomer | 1983 |
Suppression of tubular anion transport by an inhibitor of serum protein binding in uremia.
Topics: Animals; Biological Transport; Blood Proteins; Humans; Kidney Failure, Chronic; Kidney Tubules; Niac | 1981 |
Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.
Topics: Adolescent; Adult; Aged; Aging; Coronary Disease; Gout; Humans; Hypertension; Inulin; Kidney; Kidney | 1982 |
The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.
Topics: Acetylation; Adult; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Injections, Intrave | 1993 |
Effects of IGF-I on renal function in patients with chronic renal failure.
Topics: Adolescent; Adult; Female; Glomerular Filtration Rate; Humans; Insulin-Like Growth Factor I; Inulin; | 1993 |
MR velocity mapping measurement of renal artery blood flow in patients with impaired kidney function.
Topics: Aged; Blood Flow Velocity; Chromium Radioisotopes; Edetic Acid; Electrocardiography; Female; Humans; | 1996 |
Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure.
Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Drug Tolerance; Female; Hemodynamics; Humans; Insulin- | 1997 |
Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Topics: Adolescent; Azathioprine; Biopsy; Chelating Agents; Child; Child, Preschool; Chromium Radioisotopes; | 1997 |
Glomerular filtration rate measurement in cirrhotic patients with renal failure.
Topics: Creatinine; Female; Glomerular Filtration Rate; Humans; Inulin; Kidney Failure, Chronic; Liver Cirrh | 1998 |
Simultaneous determination of inulin and p-aminohippuric acid in plasma and urine by reversed-phase high-performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; Humans; Insulin; Kidney Failure, Chronic; Male; p-Amino | 2001 |
High-throughput multi-analyte screening for renal disease using capillary electrophoresis.
Topics: Creatine; Creatinine; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Kidney Failure | 2001 |
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
Topics: Animals; Anions; Biological Transport; Dose-Response Relationship, Drug; Female; Furans; Indican; Ki | 2002 |
Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency.
Topics: Aged; Aspirin; Diuresis; Drug Interactions; Female; Furosemide; Glomerular Filtration Rate; Humans; | 1977 |
Effect of fenoldopam in dogs with spontaneous renal insufficiency.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Animals; Creatinin | 1990 |
Renal tolerance for ioxaglate in patients with chronic renal failure.
Topics: Adult; Aged; Coronary Angiography; Glomerular Filtration Rate; Humans; Inulin; Ioxaglic Acid; Kidney | 1991 |
Converting enzyme inhibition in chronic renal failure.
Topics: Adult; Body Weight; Captopril; Creatinine; Female; Humans; Hypertension, Renal; Inulin; Kidney Failu | 1989 |
Differential effects of the degree of renal damage on p-aminohippuric acid and inulin clearances in rats.
Topics: Aminohippuric Acids; Animals; Dose-Response Relationship, Drug; Inulin; Kidney; Kidney Failure, Chro | 1989 |